Arrival, Registration, Session I, Welcome Reception
|
Time |
Block |
Topic |
Speaker(s) |
Format |
|
12:30-14:00 |
|
Arrival and check-in |
|
Open |
|
14:00-16:00 |
|
Conference registration |
|
Open |
|
16:00-16:30 |
Session I |
Welcome, IISFD mission, and meeting objectives |
Arturo Casadevall |
15 + 15 |
|
16:30-17:00 |
Session I |
Opening keynote: Why immunotherapy now? The efficacy ceiling of antifungal therapy and the unmet need for adjunctive immune trials |
Dimitrios Kontoyiannis |
20 + 10 |
|
17:00-17:30 |
Session I |
Architecting the Immune Response in Invasive Fungal Disease: Building a New Era of Clinical Immunotherapy |
Frank van de Veerdonk |
20 + 10 |
|
17:30-18:00 |
Session I |
Regulatory and trial-framework considerations for immune interventions in infection |
TBC (John Powers) |
20 + 10 |
|
18:00-19:00 |
Session I |
WORKSHOP: Trial-design primer and plenary discussion: what should first-generation fungal immunotherapy studies look like? |
Chair + panel discussion |
Panel / workshop |
|
19:00-22:30 |
|
Welcome Reception and Dinner |
All faculty |
Social / networking |
Sessions II-IV, Poster Viewing, Conference Dinner
|
Time |
Block |
Topic |
Speaker(s) |
Format |
|
07:30-08:45 |
|
Breakfast |
|
|
|
09:00-09:30 |
Session II |
Therapeutic toolbox for fungal immunotherapy: cytokines, monoclonal antibodies, checkpoint concepts, and emerging cellular approaches |
Darius Armstrong |
20 + 10 |
|
09:30-10:00 |
Session II |
Engineered immune interventions and cellular platforms: what can be borrowed from cancer immunotherapy? |
Katy Rezvani |
20 + 10 |
|
10:00-10:30 |
Session II |
Precision immune modulation and synthetic immunology: future directions for host-directed therapy |
Manish Butte |
20 + 10 |
|
10:30-11:30 |
|
Coffee break and poster viewing |
|
|
|
11:30-12:00 |
Session III |
Candidiasis, inborn errors of immunity, and immunotherapy opportunities |
Fanny Lanternier |
20 + 10 |
|
12:00-12:30 |
Session III |
Cryptococcosis and candidiasis: trial pitfalls |
Tihana Bicanic |
20 + 10 |
|
12:30-13:00 |
Session III |
Cryptococcosis across the translational spectrum: from host damage to pragmatic therapeutic strategy |
John Perfect |
20 + 10 |
|
13:00-14:30 |
|
Lunch and informal discussions |
|
|
|
14:30-15:00 |
Session IV |
Teaching host biology in infectious diseases: building the next generation of clinician-scientists |
Jay Vyas |
20 + 10 |
|
15:00-15:30 |
Session IV |
Immune balance, host injury, and sepsis-informed frameworks for fungal disease |
Thierry Calandra |
20 + 10 |
|
15:30-16:00 |
Session IV |
From stewardship to innovation: integrating antifungal development, trial design, and clinical implementation |
Melissa Johnson |
20 + 10 |
|
16:00-16:30 |
|
Coffee / transition |
|
|
|
16:30-17:00 |
Session IV |
Innovative functional immune assays for patient stratification and immunological trial readouts |
Georgios Chamilos |
20 + 10 |
|
17:00-17:30 |
Session IV |
Immune regulation, tolerance, and restoration of antifungal defense |
Luigina Romani |
20 + 10 |
|
17:30-18:00 |
Session IV |
Translating core human immunology into antifungal immunotherapy |
Mihalis Lionakis |
20 + 10 |
|
18:00-18:30 |
Session IV |
Selected abstract short talks 4-6: translational immunology, assays, and trial-ready biomarkers |
3 selected abstract presenters |
3 x 10 |
|
18:30-19:15 |
Session IV |
WORKSHOP: what should we test now, and what should we stop doing, in fungal immunotherapy? |
Chair + panel discussion |
Debate |
|
19:30-late |
|
Conference dinner |
|
|
Sessions V-VII, Closing Remarks, Farewell Dinner
|
Time |
Block |
Topic |
Speaker(s) |
Format |
|
07:30-08:45 |
|
Breakfast |
|
|
|
09:00-09:30 |
Session V |
Aspergillosis in the ICU and beyond: immune dysregulation, phenotypes, and trial opportunities |
Joost Wauters |
20 + 10 |
|
09:30-10:00 |
Session V |
Host biology in aspergillosis: mechanisms, endotypes, biomarkers, and actionable targets |
Agostinho Carvalho |
20 + 10 |
|
10:00-10:30 |
Session I |
Selected abstract short talks 1-3: immune phenotypes, biomarkers, and early translational signals |
3 selected abstract presenters |
3 x 10 |
|
10:30-11:30 |
|
Coffee break and poster viewing |
|
|
|
11:30-12:00 |
Session VI |
Mucormycosis: immunomodulatory strategies and translational priorities |
Ashraf Ibrahim |
20 + 10 |
|
12:00-12:30 |
Session VI |
Rewiring Innate Immunity: Inflammasomes in Host Protection and Pathology |
Thirumala Kanneganti |
20 + 10 |
|
12:30-13:00 |
Session VI |
Trained immunity, tissue responses, and immunometabolism in severe infection |
Maziar Divangahi |
20 + 10 |
|
13:00-14:30 |
|
Lunch and informal discussions |
|
|
|
14:30-15:00 |
Session VII |
Adaptive and platform trial designs: lessons from REMAP-CAP and critical care networks |
Lennie Derde |
20 + 10 |
|
15:00-15:30 |
Session VII |
Fungal biology as a therapeutic entry point: cell wall, morphogenesis, and host-facing targets |
Carol Munro |
20 + 10 |
|
15:30-16:00 |
Session VII |
WORKSHOP: How to make it practical: regarding patients, fungal specimens, and logistics of cellular and non-cellular therapies? |
Chair + panel discussion |
|
|
16:00-17:30 |
Session VII |
IISFD roadmap roundtable: working groups, assay harmonization, trial networks, education, and shared resources |
Roundtable |
including policy makers EU/NIH |
|
17:30-17:45 |
Closing remarks |
Meeting summary, next steps, and launch priorities |
Arturo Casadevall |
Closing |
|
19:30-late |
|
Farewell dinner Special Aegean farewell event |
|
|
Breakfast, Departure, Optional Working-Group Huddles
|
Time |
Block |
Topic |
Speaker(s) |
Format |
|
07:30-10:30 |
|
Breakfast |
|
|
|
11:00 |
|
Departure and check-out |
|
|